CCL2 and obesity disorder: The evidence from experimental studies revealed the potential benefits of VD on MCP-1, as demonstrated by a significant decrease in the mRNA expression and levels of MCP-1 across different rodent models of prediabetes, obesity and diabetes mellitus.